Integrated Behavioral Health For Substance Use Disorders And Co-Occurring Mental Health Disorders In Underserved U.S. Settings: A Scoping Review Of Care Models, Implementation, And Outcomes

Authors

  • John Smart Mgbakor PhD, MA, CASAC, LMHC-LP, Addiction Counselor and Behavioral Health Professional, Bronx, New York, United States

DOI:

https://doi.org/10.69980/ajpr.v29i1.951

Keywords:

Substance-Related Disorders;, Mental Disorders, Delivery of Health Care, Integrated, Implementation Science, Medically Underserved Area, Primary Health Care, Vulnerable Populations, Health Services Accessibility

Abstract

Background: Substance use and co-occurring mental health disorders are common, but only a small percentage of adults with these disorders in the U. S. receive treatment for both conditions. Integrated behavioral health care has been suggested as one approach to address this treatment gap. However, we know little about how integrated models are designed, implemented, and evaluated in settings that serve underserved populations.

Objective: To assess the peer-reviewed and grey literature on integrated behavioral health services for adults with substance use disorders (SUD) and co-occurring mental health disorders (MH) in underserved U. S. settings in order to characterize models of care, frameworks for implementation, reported outcomes, barriers and facilitators to implementation.

Methods: A scoping review was performed following JBI methodology and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) guidance. Seven bibliographic databases and six governmental websites were searched to identify records published in 2020 onward. Two reviewers screened records and extracted data; descriptive numerical summary and thematic narrative were used to synthesize results.

Results: Of 6,060 records identified, 74 studies including 38,642 participants were eligible. Collaborative Care was the most common model studied (28 studies; 37.8%) and Federally Qualified Health Centers were the most common setting (23 studies; 31.1%). Explicit implementation frameworks were utilized in 50 studies (67.6%). Reduced substance use (55 studies; 74.3%) and improved depression (48 studies; 64.9%) were reported most often. Workforce shortages (42 studies; 56.8%) and multidisciplinary teams (46 studies; 62.2%) were reported most frequently as barriers and facilitators respectively.

Conclusions: Team-based models of integrated behavioral health for co-occurring disorders implemented in safety-net primary care settings continue to prevail in underserved communities where workforce and financing limitations are common. We recommend transparent reporting of implementation efforts and equity-focused evaluation moving forward.

References

1. Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., et al. (2012). Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews, (10), CD006525. https://doi.org/10.1002/14651858.CD006525.pub2

2. Arksey, H., & O'Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19–32. https://doi.org/10.1080/1364557032000119616

3. Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M., & Stetler, C. (2012). Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Medical Care, 50(3), 217–226. https://doi.org/10.1097/MLR.0b013e3182408812

4. Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science, 4, 50. https://doi.org/10.1186/1748-5908-4-50

5. Damschroder, L. J., Reardon, C. M., Widerquist, M. A. O., & Lowery, J. (2022). The updated Consolidated Framework for Implementation Research based on user feedback. Implementation Science, 17(1), 75. https://doi.org/10.1186/s13012-022-01245-0

6. Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., et al. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52(4), 469–476. https://doi.org/10.1176/appi.ps.52.4.469

7. Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: The RE-AIM framework. American Journal of Public Health, 89(9), 1322–1327. https://doi.org/10.2105/ajph.89.9.1322

8. Levac, D., Colquhoun, H., & O'Brien, K. K. (2010). Scoping studies: Advancing the methodology. Implementation Science, 5, 69. https://doi.org/10.1186/1748-5908-5-69

9. May, C., & Finch, T. (2009). Implementing, embedding, and integrating practices: An outline of normalization process theory. Sociology, 43(3), 535–554. https://doi.org/10.1177/0038038509103208

10. McGinty, E. E., & Daumit, G. L. (2020). Integrating mental health and addiction treatment into general medical care: The role of policy. Psychiatric Services, 71(11), 1163–1169. https://doi.org/10.1176/appi.ps.202000183

11. McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016). PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. Journal of Clinical Epidemiology, 75, 40–46. https://doi.org/10.1016/j.jclinepi.2016.01.021

12. Meredith, L. S., Eisenman, D. P., Han, B., Green, B. L., Kaltman, S., Wong, E. C., et al. (2016). Impact of collaborative care for underserved patients with PTSD in primary care: A randomized controlled trial. Journal of General Internal Medicine, 31(5), 509–517. https://doi.org/10.1007/s11606-016-3588-3

13. Munn, Z., Peters, M. D. J., Stern, C., Tufanaru, C., McArthur, A., & Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology, 18(1), 143. https://doi.org/10.1186/s12874-018-0611-x

14. Office of Disease Prevention and Health Promotion. (n.d.). Increase the proportion of people with substance use and mental health disorders who get treatment for both — MHMD-07. U.S. Department of Health and Human Services. https://odphp.health.gov/healthypeople/

15. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71

16. Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., et al. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis, 18(10), 2119–2126. https://doi.org/10.11124/JBIES-20-00167

17. Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/10.1016/j.jsat.2015.09.006

18. Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., et al. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health, 38(2), 65–76. https://doi.org/10.1007/s10488-010-0319-7

19. Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., et al. (2021). PRISMA-S: An extension to the PRISMA statement for reporting literature searches in systematic reviews. Systematic Reviews, 10(1), 39. https://doi.org/10.1186/s13643-020-01542-z

20. Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/

21. Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850

22. Unützer, J., Katon, W., Callahan, C. M., Williams, J. W., Jr., Hunkeler, E., Harpole, L., et al. (2002). Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA, 288(22), 2836–2845. https://doi.org/10.1001/jama.288.22.2836

23. Watkins, K. E., Ober, A. J., Lamp, K., Lind, M., Setodji, C. M., Osilla, K. C., et al. (2017). Collaborative care for opioid and alcohol use disorders in primary care: The SUMMIT randomized clinical trial. JAMA Internal Medicine, 177(10), 1480–1488. https://doi.org/10.1001/jamainternmed.2017.3947

Downloads

Published

2026-02-06